Titlebook: Concepts and Controversies in Obsessive-Compulsive Disorder; Jonathan S. Abramowitz,Arthur C. Houts Book 2005 Springer-Verlag New York 200

Canopy

Helmut Neunzert,Abul Hasan Siddiqivalent, and chronically disabling disorder affecting between 1% and 3% of the population worldwide (Rasmussen & Eisen, 1994), empirically supported cognitive-behavioral and pharmacological treatments are available for OCD (March & Leonard, 1998). The clinical phenomenology/nosology and empirical tre

梯田

VOC

交響樂

Topics in Inorganic and Physical Chemistryce of exposurebased treatment, OCD was largely considered to be chronic. In its severe forms, it was associated with substantial long-term disability. The advent of exposure therapy (Meyer, 1966) was a therapeutic breakthrough that revolutionized psychotherapy for OCD and afforded relief to many ind

hematuria

陳舊

https://doi.org/10.1007/978-3-030-65509-9P) has become firmly established as a highly effective method for reducing symptoms of the disorder (see Abramowitz, 1997; van Balkom et al., 1994, for reviews). However, as several authors have noted (Foa & Kozak, 1986; Steketee & Barlow, 2002), no one is entirely sure why exposure is effective. It

anarchist

Studies in Systems, Decision and Controlrotonin reuptake inhibitors) and cognitive-behavioral therapy (CBT) consisting of exposure and response prevention (ERP). Expert consensus treatment guidelines for adults with OCD (March, Frances, Carpenter, & Kahn, 1997) recommend ERP monotherapy be offered to every OCD patient when available and t

虛構(gòu)的東西

https://doi.org/10.1007/b101087Syndrom; etiology; pharmacotherapy; syndromes; therapy

內(nèi)疚

choleretic

Jonathan S. Abramowitz,Arthur C. HoutsCompares and contrasts different viewpoints on OCD by experts in the field.Includes supplementary material: